Brief: 3Sbio Inc Says Clinical Trial Application Of Group's Drug Approved
18/09/2019 13:53
Sept 18 (Reuters) - 3SBio Inc 1530.HK :
* CLINICAL TRIAL APPLICATION OF GROUP'S DRUG TO TREAT
PRURITUS OF
HEMODIALYSIS PATIENTS APPROVED BY NATIONAL MEDICAL PRODUCTS
ADMINISTRATION
Source text for Eikon: urn:newsml:reuters.com:*:nHKS2nPmvH
Further company coverage: 1530.HK
((Reuters.Briefs@thomsonreuters.com;))